Geratherm Medical AG

Earnings Release • Mar 8, 2011

News Details

Ad-hoc | 8 March 2011 08:12

Geratherm Medical AG: Geratherm Medical announces preliminary figures for 2010

Geratherm Medical AG / Key word(s): Preliminary Results

08.03.2011 08:12

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

DGAP ad hoc: Geratherm Medical announces preliminary figures for 2010

Ad hoc announcement according to § 15 of the WpHG (German Securities
Trading Act) transmitted by DGAP - a company of Equity Story AG. The issuer
is responsible for the contents of the announcement.

Geratherm Medical announces preliminary figures for 2010
Continued strong growth in revenue and earnings

• Turnover 17 million EUR + 18,0 %

• EBITDA 2,948 kEUR + 13.1 %

• EBITDA margin 17.4 % (p.y: 18.1 %)

• EBIT 2.4 million EUR + 5.0 %

• Financial result 983 kEUR + 75.6 %

• Result of ordinary activities 3,333 kEUR + 19.2 %

• Shareholders' (EAT) result 2,712 kEUR + 1.2 %

• Dividend recommendation 40 cents per share (tax-neutral)

Geschwenda, 08. March 2011 - Geratherm Medical again showed positive growth
in the financial year. Turnover increased by 18.0 % to 17 million EUR.
Gross profit, at 21.8 % growth, was above the declared growth in turnover.
The gross margin is 62.5 %.

The below-average increase in the operating result (EBIT) derives from the
substantial increase in depreciations, principally on intangible assets
which, at 269 kEUR, were more than double those in the comparable period of
the previous year. Intangible assets principally consist of capitalised
research and development costs, which are depreciated for the first time
with the commercial launch of the products.

Including financial yields, Geratherm Medical records a result from
ordinary activities of 3,333 kEUR for the year 2010. This is the best
result to date in the company history of Geratherm Medical.

The availment of existing losses carried forward leads on an IFRS basis to
an increased burden of deferred taxes amounting to -590 kEUR. These are
however non-cash. As a result of these taxes, burdening specifically
according to IFRS regulations, it was only possible to record a
shareholders' result of the parent company on a par with that of the
previous year, at 2,712 kEUR.

Outlook: it is highly probable that, given the same general conditions,
company and revenue growth will continue in 2011.

The preliminary figures are subject to the report of the independent
auditors and the approval of the supervisory board.

The final figures for the 2010 financial year and the annual report will be
published on 20th April 2011.

Short company profile:
Geratherm Medical is an internationally operating medical products
enterprise with the business areas 'Temperature Management', 'Cardio' and
'Respiratory'.

Our company's roots are in temperature measurement in the medical sphere.
In this business area we offer a broad spectrum of products, most of which
have unique selling points. We supply our customers/patients with
high-quality products ranging from thermometers to complex warming systems
for use in the operating theatre and by emergency rescue services. In the
Cardio business area we concentrate on the development of products for the
detection of atrial fibrillation as a measure to prevent strokes. The
Respiratory segment develops and markets products for the assessment of
pulmonary function.

In all three business areas, Geratherm has patent-protected basic
technologies at its disposal. We regard ourselves as a research-based
medical products company with a clear focus on medical diagnostic devices
that generate vital data.

Geratherm shares have been listed in the Prime Standard segment of the
Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues
to be represented in the German Entrepreneurial Index and in the German
Health-Care Index.

Geratherm Medical AG, Investor Relations
Fahrenheitstraße 1, 98716 Geschwenda
Tel. +49 (0)36205/98 111, E-Mail: info@geratherm.com www.geratherm.com
Emittent: Geratherm Medical AG, Fahrenheitstraße 1, 98716 Geschwenda
Deutschland
Tel. 036205/98 111 Fax: 036205/98 115
ISIN : DE 000 549 562 6
WKN : 549 562
Börsen : Frankfurter Wertpapierbörse /Geregelter Markt/Prime Standard
Börse: Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, München,
Stuttgart

• Ende der Mitteilung -

08.03.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: Geratherm Medical AG
Fahrenheitstraße 1
98716 Geschwenda
Deutschland
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: info@geratherm.com
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, München, Stuttgart

End of Announcement DGAP News-Service

---